Filing Flows › agilon health (AGL) › Q2 2026
agilon health (AGL) Q2 2026 earnings results (second quarter 2026)
10-Q filed Aug 5, 2026
agilon health (AGL) reported revenue of $1.5B for the second quarter 2026 (Q2 2026), +7% from a year earlier and +5% from the quarter before. Operating margin was 0.8%, net earnings $18.0M (1.2% of revenue).
agilon health, Q2 2026: revenue $1.5B (+7% year over year), operating margin 0.8%, net earnings $18.0M, operating cash flow −$57.3M. The chart follows the revenue to costs, profit and cash.
| Q2 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5B | +5% | +7% |
| Operating profit | $11.8M | +194% | — |
| Net earnings | $18.0M | -63% | — |
| Operating cash flow | −$57.3M | -341% | — |
What changed
Revenue was $1.5B in Q2 2026, up 7% year over year and up 5% from the previous quarter. Medical services revenue was the largest line at 100% of revenue. Medical services revenue added $0.10B year over year (up 7%), 101% of the total change. Other operating revenue declined 38%.
Operating profit was $0.01B, a 0.8% margin (up 9.1 points year over year). Total costs fell 2% while revenue rose 7%. The fastest-growing cost line was General & admin (+57%). Net earnings were $0.02B. The effective tax rate was -2.1%. Non-operating items added $0.01B, 33% of pre-tax earnings, so the bottom line overstates operating performance.
Operating cash flow was −$0.06B. Non-cash charges added back $0.01B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.11B. Capital expenditures of $3.4M exceeded it, leaving free cash flow of −$0.06B.
Questions
What was agilon health's revenue in the second quarter 2026?
agilon health (AGL) reported revenue of $1.5B for the second quarter 2026 (Q2 2026), +7% from a year earlier and +5% from the quarter before.
Was agilon health profitable in the second quarter 2026?
Operating profit was $11.8M (0.8% of revenue) and net earnings $18.0M.
Source: agilon health 10-Q on SEC EDGAR.